Montelukast mood symptoms — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Seek prescriber review promptly and discuss possible neuropsychiatric adverse effects
Montelukast has recognised neuropsychiatric adverse effects and new symptoms should be reviewed. In this vignette, "Seek prescriber review promptly and discuss possible neuropsychiatric adverse effects" is the safest single best answer. The other options are less appropriate because they miss the key clinical risk, conflict with UK medicines guidance, or delay needed review.
Reference: BNF; NICE CKS